BioRem Inc. (TSXV:BRM)
Canada · Delayed Price · Currency is CAD 3.750
+0.040 (1.08%)
Nov 3, 2026, 4:00 PM EST
BioRem Earnings Call Transcripts
Fiscal Year 2026
-
YTD bookings neared CAD 50m, backlog exceeded CAD 70m and the active funnel topped CAD 220m. Service revenue reached CAD 4m in H1, supporting a push toward recurring revenue.
Fiscal Year 2025
-
Management reduced outstanding shares by 60% through a strategic buyback, strengthening capital structure. The business is experiencing strong organic growth, driven by new products and services, with a record backlog and expanding service revenue. Market demand is supported by infrastructure upgrades, regulatory trends, and a disciplined M&A approach.